Intuitive Surgical (NASDAQ:ISRG) Stock Price Down 0.2% – What’s Next?

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock price fell 0.2% during trading on Thursday . The company traded as low as $586.63 and last traded at $589.47. 235,658 shares changed hands during trading, a decline of 87% from the average session volume of 1,880,671 shares. The stock had previously closed at $590.90.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Finally, Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Down 0.9 %

The company has a 50-day moving average of $554.85 and a 200 day moving average of $513.96. The stock has a market capitalization of $207.65 billion, a PE ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,940 shares of company stock valued at $3,333,485 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the company. State Street Corp increased its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC grew its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC increased its stake in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its position in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the period. Finally, Baillie Gifford & Co. lifted its stake in shares of Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.